TY - JOUR T1 - Retrospective Assessment of Treatments of Hospitalized Covid-19 Patients JF - medRxiv DO - 10.1101/2021.04.20.21255792 SP - 2021.04.20.21255792 AU - Ghooi Ravindra AU - Lele Chitra AU - Motwani Madhur AU - Dixit Santosh AU - Premnath Venugopalan AU - Salvi Sundeep AU - Bhat Shreepad AU - Chaudhari Piyush AU - D’Costa Pradeep AU - Jahagirdar Ashwini AU - Mane Abhay AU - Padbidri Vikram AU - Pande Chetan AU - Shukla Urvi Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/05/2021.04.20.21255792.abstract N2 - Infection with SARS-Cov-2 virus, is associated with significant morbidity and mortality, in addition to the economic burden it has put on the country. While waiting for a vaccine that gives adequate protection, it is necessary to understand the course of the infection and identify drugs that could reduce its impact. The results of this multicenter study involving 1035 hospitalized patients in Pune, identified diabetes, hypertension and low lymphocyte counts as predictors of mortality. There is also an indication that multiple comorbidities add to risk of severe disease and mortality. Data from metformin treated diabetics raises the possibility of considering repurposing of this drug in a larger study. It is also noted that Hydroxychloroquine, dexamethasone, azithromycin and remdesivir were associated with lower overall mortality. Diabetes and hypertension put Covid infected patients at greater risk of death, coexistence of both diseases further augment the risk, and must be aggressively treated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to acknowledge the financial grant from Persistent Systems, for the conduct of this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The current study was approved by the Institutional Ethics Committee of Jehangir Hospital, PuneAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data reported in the manuscript will be accessible with prior knowledge of the Ethics Committee overseeing the study . ER -